The Providence Cancer Institute of Oregon is known for its highly personalized approach to cancer care, enhanced by innovative technologies and therapies. The institute delivers comprehensive services that include genomic sequencing, immunotherapy and a full spectrum of radiation oncology treatments. Among its treatment options, it hosts the only MRI linear accelerator in the Pacific Northwest that facilitates a higher level of accuracy in the delivery of radiation treatment. It also administers advanced therapies such as CAR T-cell and tumor-infiltrating lymphocyte therapy. The institute led a pivotal global clinical trial for ipilimumab, an immune checkpoint therapy that significantly advanced cancer care and contributed to a Nobel Prize in medicine. With more than 25 years of immunotherapy research, Providence has an extensive clinical trial portfolio, including a novel bacterial-based vaccine for glioblastoma multiforme. Beyond its medical treatments, the institute also prioritizes holistic care, offering services such as genetic counseling, naturopathy, cardiovascular protection and spiritual care.
Back to list

Becker's Recognition
Providence Cancer Institute of Oregon (Portland)has been named a Becker's honoree on the lists below.
2024 Winner

Hospital & Health Systems
Hospital and Health Systems With Great Oncology Programs
These organizations have earned national recognition for their work in cancer care. These programs offer leading-edge clinical trials and pioneer research discoveries that expand access to care and enhance patient outcomes.
Oncology
